Ilika plc makes senior appointments and change of director

Ilika plc

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, has today provided an update on senior appointments and a planned change of Director.

To further support the development and commercialisation of Ilika’s solid-state battery products, Ilika has made two senior additions to its management team, creating two new positions:

Goliath Operations Director – With immediate effect, Ilika has appointed Brendan McCarthy. Brendan was most recently Operations Director at the UK Battery Industrialisation Centre (UK-BIC) and prior to that had a long career at BMW where he held a variety of UK-based and international operational roles.

VP Product Development – With effect from 1 November 2021, Ilika has appointed Robin Bell. Robin is currently Chief Operating Officer at Inflowmatix, which has recently been acquired by Suez. Prior to that, Robin was Director of Product Development at SPI Lasers (Trumpf GmbH).

Robin will take over line management responsibility for Ilika’s Stereax and Goliath product development programmes from Prof Brian Hayden, who will step down as a Statutory Director of Ilika plc at Ilika’s forthcoming AGM on 22 September 2021. Brian will retain the position of Chief Scientific Officer in the Company in a consulting role which will be focussed on delivering rapid technical solutions to the development teams.

Ilika plc CEO Graeme Purdy, stated, “We are delighted to welcome Brendan and Robin to our team. They will build on the product development momentum created so far and bring their substantial operational expertise to bear on the execution of our product roadmaps. We look forward to continuing our long relationship with Brian in his new technical consulting role.”

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Ilika secures first commercial Stereax electrode order from Cirtec Medical

Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production.

Solid state design drives weight, cost and efficiency gains

Solid state design offers Ilika a compelling path to value through weight savings, pack simplification and improved EV performance.

Ilika aligns solid state production with lithium-ion supply chains

Ilika’s Goliath batteries are being scaled with standard lithium-ion tools and low-cost materials to match today’s battery economics.

Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress

Take a look back at Ilika’s 2025 progress, as the company moved from laboratory validation to manufacturing, delivering key Stereax and Goliath solid-state battery milestones.

Search

Search